Covaxin
Augmentation of Manufacturing Capacity for COVAXIN Production Under Mission COVID Suraksha
DCGI Approves Phase II/III Clinical Trial of COVAXIN Among Age Group of 2 to 18 Years
White House's Dr. Fauci Finds Bharat Biotech's Covaxin Capable to Fight 617 Variant of COVID
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
/smstreet/media/post_banners/wLauSQT1Ev0kY1Q4wKj9.jpg)
/smstreet/media/post_banners/SZcUzoqJKO4Js6EUJmH4.jpeg)
/smstreet/media/post_banners/rTqhqHOQFbZqKgol5DA9.png)
/smstreet/media/post_banners/IJIE14E1uxMMA5v3fmSg.png)
/smstreet/media/post_banners/xxGKIAwRJbiwaAaeLLkj.png)
/smstreet/media/post_banners/ftghUC3TFcOs9ocslMtX.jpg)
